OOMA heads into the post-earnings window with the stock trading 20% higher on the month and analysts scrambling to revise targets upward following a clean Q1 beat.
Ooma reported Q1 FY2027 adjusted EPS of $0.35 against a $0.32 estimate, and revenue of $81.1 million against a $79.8 million consensus. That's not just a number — it's a meaningful beat in a name where the bar had been set cautiously after margin compression concerns dominated the prior quarter narrative. The company also lifted its full-year guidance. FY2027 adjusted EPS guidance moved to $1.29–$1.34, up from $1.26–$1.31, while revenue guidance was raised to $326–$328.5 million against a prior range of $321–$325 million and a consensus sitting around $322.8 million. Q2 guidance — EPS of $0.33–$0.34 and revenue of $81.6–$82.3 million — topped estimates on both lines as well.
The analyst response was immediate. Both of the firm's core coverage names lifted targets this morning. Lake Street raised its price target to $23 from $18, maintaining Buy. Benchmark moved to $24 from $23, also keeping Buy. The mean target now sits at $22.66. With the stock at $19.27, that implies roughly 18% upside to consensus — a gap that reflects the market still pricing in some skepticism. The Street's direction of travel is clear: coverage that retained Buy ratings through weaker quarters has now moved targets above the previous consensus range. JMP Securities continues to carry a Market Perform, providing a lone note of caution.
Options traders turned strongly bullish ahead of the result and have held that posture. The put/call ratio is near a 52-week low at 0.032, far below the 20-day average of 0.080. That skew is as one-sided as it has been all year — call demand dominates, consistent with a market that bought into the earnings story and has not yet rotated into hedging the move. The short interest backdrop offers nothing to complicate that picture. Short interest is just 2.6% of free float, trimmed roughly 6% over the past month as the stock rallied, and borrow availability is extraordinarily loose at over 7,300% of short interest. Cost to borrow has doubled over the past week to 0.86%, but at that absolute level, it signals noise rather than any meaningful demand for new short positions.
The valuation picture is worth framing correctly given the stock's move. The P/E has re-rated sharply, climbing roughly 14 points over the past 30 days to 14.3x — a function of the price gain rather than earnings revision lag. Price-to-book has expanded to 5.2x, up 0.7x over the same period. EV/EBITDA is near 12.3x. For a business growing revenue at 3–4% with gross margins around 62%, these multiples are not demanding, but neither are they cheap. The factor picture reflects a company in the middle of the pack — EPS momentum scores around the 40s, short score rank at 55, and sector score at 50. The value pillar remains the weakest link: the EV/EBIT factor score ranks in the 4th percentile, flagging that earnings-based valuation metrics still sit at a premium on a relative basis.
Among correlated peers, the week's backdrop was mixed. ZS gained 5.7% on the week, while WDAY fell 3.8% and VERX slipped 1.5%. OOMA's own 1.2% weekly decline looks modest against that spread — the stock's post-earnings strength has effectively decoupled it from the group's mid-week pressure. The next formal event to watch is June 4, listed in the calendar, likely an investor or analyst call. With guidance raised and two buy-side targets freshly lifted, the June event and any further gross margin commentary will be the focal points for whether the current re-rating holds.
See the live data behind this article on ORTEX.
Open OOMA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
